Average Co-Inventor Count = 7.40
ph-index = 6
The patent ph-index is calculated by counting the number of publications for which an author has been cited by other authors at least that same number of times.
Company Filing History:
1. Exelixis, Inc. (13 from 173 patents)
2. University of California (8 from 15,458 patents)
3. Symphony Evolution, Inc. (4 from 10 patents)
4. Atlasmedx, Inc. (3 from 3 patents)
5. Other (1 from 832,680 patents)
6. Rescue Therapeutics, Inc. (1 from 1 patent)
7. Rascal Therapeutics, Inc. (1 from 1 patent)
26 patents:
1. 12227482 - Compounds and compositions for the treatment of cancer
2. 12145925 - Phthalazine derivatives as inhibitors of PARP1, PARP2, and/or tubulin useful for the treatment of cancer
3. 11708352 - Anti-cancer compounds
4. 11597699 - MEK inhibitors and methods of their use
5. 11560356 - Compounds and compositions for the treatment of cancer
6. 11149025 - Anti-cancer compounds
7. 11072600 - Phthalazine derivatives as inhibitors of PARP1, PARP2, and/or tubulin useful for the treatment of cancer
8. 10640493 - Phthalazine derivatives as inhibitors of PARP1, PARP2, and/or tubulin useful for the treatment of cancer
9. 10562886 - Anti-cancer compounds
10. 10266518 - Solid dosage formulations of substituted quinazoline receptor-type kinase modulators and methods of use thereof
11. 9796704 - Substituted quinazolines as receptor-type kinase inhibitors
12. 9359332 - Processes for the preparation of substituted quinazolines
13. 8697737 - Raf modulators and methods of use
14. 8658654 - Receptor-type kinase modulators and methods of use
15. 8648066 - Benzoxazepines as inhibitors of PI3K/mTOR and methods of their use and manufacture